Gregg W Stone1, Akiko Maehara2, James E Muller3, David G Rizik4, Kendrick A Shunk5, Ori Ben-Yehuda2, Philippe Genereux6, Ovidiu Dressler7, Rupa Parvataneni7, Sean Madden3, Priti Shah3, Emmanouil S Brilakis8, Annapoorna S Kini9. 1. Columbia University Medical Center and New York-Presbyterian Hospital, New York, New York; The Cardiovascular Research Foundation, New York, New York. Electronic address: gs2184@columbia.edu. 2. Columbia University Medical Center and New York-Presbyterian Hospital, New York, New York; The Cardiovascular Research Foundation, New York, New York. 3. InfraReDx Inc., Burlington, Massachusetts. 4. Scottsdale Healthcare, Scottsdale, Arizona. 5. San Francisco Veterans Affairs Medical Center, San Francisco, California. 6. The Cardiovascular Research Foundation, New York, New York; Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada. 7. The Cardiovascular Research Foundation, New York, New York. 8. North Texas Veterans Affairs Medical Center, Dallas, Texas. 9. Mount Sinai Hospital, New York, New York.
Abstract
OBJECTIVES: This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies lipid-rich plaques at risk of periprocedural myonecrosis and whether these events may be prevented by the use of a distal protection filter during PCI. BACKGROUND: Lipid-rich plaques may be prone to distal embolization and periprocedural myocardial infarction (MI) in patients undergoing PCI. METHODS:Patients undergoing stent implantation of a single native coronary lesion were enrolled in a multicenter, prospective trial. Near-infrared spectroscopy and intravascular ultrasound were performed at baseline, and lesions with a maximal lipid core burden index over any 4-mm length (maxLCBI4mm) ≥600 were randomized to PCI with versus without a distal protection filter. The primary endpoint was periprocedural MI, defined as troponin or a creatine kinase-myocardial band increase to 3 or more times the upper limit of normal. RESULTS:Eighty-five patients were enrolled at 9 U.S. sites. The median (interquartile range) maxLCBI4mm was 448.4 (274.8 to 654.4) pre-PCI and decreased to 156.0 (75.6 to 312.6) post-PCI (p < 0.0001). Periprocedural MI developed in 21 patients (24.7%). The maxLCBI4mm was higher in patients with versus without MI (481.5 [425.6 to 679.6] vs. 371.5 [228.9 to 611.6], p = 0.05). Among 31 randomized lesions with maxLCBI4mm ≥600, there was no difference in the rates of periprocedural MI with versus without the use of a distal protection filter (35.7% vs. 23.5%, respectively; relative risk: 1.52; 95% confidence interval: 0.50 to 4.60, p = 0.69). CONCLUSIONS: Plaque characterization by near-infrared spectroscopy identifies lipid-rich lesions with an increased likelihood of periprocedural MI after stent implantation, presumably due to distal embolization. However, in this pilot randomized trial, the use of a distal protection filter did not prevent myonecrosis after PCI of lipid-rich plaques.
RCT Entities:
OBJECTIVES: This study sought to determine whether pre-percutaneous coronary intervention (PCI) plaque characterization using near-infrared spectroscopy identifies lipid-rich plaques at risk of periprocedural myonecrosis and whether these events may be prevented by the use of a distal protection filter during PCI. BACKGROUND:Lipid-rich plaques may be prone to distal embolization and periprocedural myocardial infarction (MI) in patients undergoing PCI. METHODS:Patients undergoing stent implantation of a single native coronary lesion were enrolled in a multicenter, prospective trial. Near-infrared spectroscopy and intravascular ultrasound were performed at baseline, and lesions with a maximal lipid core burden index over any 4-mm length (maxLCBI4mm) ≥600 were randomized to PCI with versus without a distal protection filter. The primary endpoint was periprocedural MI, defined as troponin or a creatine kinase-myocardial band increase to 3 or more times the upper limit of normal. RESULTS: Eighty-five patients were enrolled at 9 U.S. sites. The median (interquartile range) maxLCBI4mm was 448.4 (274.8 to 654.4) pre-PCI and decreased to 156.0 (75.6 to 312.6) post-PCI (p < 0.0001). Periprocedural MI developed in 21 patients (24.7%). The maxLCBI4mm was higher in patients with versus without MI (481.5 [425.6 to 679.6] vs. 371.5 [228.9 to 611.6], p = 0.05). Among 31 randomized lesions with maxLCBI4mm ≥600, there was no difference in the rates of periprocedural MI with versus without the use of a distal protection filter (35.7% vs. 23.5%, respectively; relative risk: 1.52; 95% confidence interval: 0.50 to 4.60, p = 0.69). CONCLUSIONS: Plaque characterization by near-infrared spectroscopy identifies lipid-rich lesions with an increased likelihood of periprocedural MI after stent implantation, presumably due to distal embolization. However, in this pilot randomized trial, the use of a distal protection filter did not prevent myonecrosis after PCI of lipid-rich plaques.
Authors: Tomasz Roleder; Magdalena Dobrolinska; Elzbieta Pociask; Wojciech Wanha; Grzegorz Smolka; Wojciech Walkowicz; Radoslaw Parma; Mariusz Lebek; Tomasz Bochenek; Przemysław Pietraszewski; Elvin Kedhi; Andrzej Ochala; Zbigniew Gasior; Ziad A Ali; Wojciech Wojakowski Journal: Cardiol J Date: 2018-09-24 Impact factor: 2.737
Authors: Farhan Chaudhry; Hideki Kawai; Kipp W Johnson; Navneet Narula; Aditya Shekhar; Fayzan Chaudhry; Takehiro Nakahara; Takashi Tanimoto; Dongbin Kim; Matthew K M Y Adapoe; Francis G Blankenberg; Jeffrey A Mattis; Koon Y Pak; Phillip D Levy; Yukio Ozaki; Eloisa Arbustini; H William Strauss; Artiom Petrov; Valentin Fuster; Jagat Narula Journal: J Am Coll Cardiol Date: 2020-10-20 Impact factor: 24.094
Authors: Jonathan A Batty; Shristy Subba; Peter Luke; Li Wing Chi Gigi; Hannah Sinclair; Vijay Kunadian Journal: Curr Cardiol Rep Date: 2016-03 Impact factor: 2.931